To enhance the peptide's longevity, a solvent with a non-toxic preservative, such as bacteriostatic water containing 0.9% benzyl alcohol, is advised
The efficacy of OZEMPIC was not impacted by age, gender, race, ethnicity, BMI at baseline, body weight (kg) at baseline, diabetes duration and level of renal function impairment
Cost and convenience differences are substantial between administration methods
NICE guidance recommends GLP-1 receptor agonists for type 2 diabetes when triple therapy is insufficient and specific BMI criteria are met, or for weight management in adults with BMI 30 kg/m (or 27 kg/m with comorbidities) through specialist services
they should be clear, colorless, and free of particles